Literature DB >> 27237590

Indoles - A promising scaffold for drug development.

T V Sravanthi1, S L Manju2.   

Abstract

Generally, heterocycles occupy a prominent place in chemistry due to their wide range of applications in the fields of drug design, photochemistry, agrochemicals, dyes and so on. Among them, indole scaffolds have been found in most of the important synthetic drug molecules and paved a faithful way to develop effective targets. Privileged structures bind to multiple receptors with high affinity, thus aiding the development of novel biologically active compounds. Among the indole class of compounds, 2-arylindoles appear to be a most promising lead for drug development. The derivatives of 2-arylindoles exhibits antibacterial, anticancer, anti-oxidants, anti-inflammatory, anti-diabetic, antiviral, antiproliferative, antituberculosis activity, etc. This article would provide a clear knowledge on the wide-ranging biological activities of 2-arylindoles over the past two decades, which would be beneficial for the designing of more potent drug targets in order to compete with the existing drugs.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2-arylindoles; Bioactive molecules; Design new therapeutics; Heterocycles; Marketed drugs; Natural alkaloids

Mesh:

Substances:

Year:  2016        PMID: 27237590     DOI: 10.1016/j.ejps.2016.05.025

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  45 in total

1.  Predictive Model for Site-Selective Aryl and Heteroaryl C-H Functionalization via Organic Photoredox Catalysis.

Authors:  Kaila A Margrey; Joshua B McManus; Simone Bonazzi; Frederic Zecri; David A Nicewicz
Journal:  J Am Chem Soc       Date:  2017-08-07       Impact factor: 15.419

2.  Photoredox Cyanomethylation of Indoles: Catalyst Modification and Mechanism.

Authors:  Connor J O'Brien; Daniel G Droege; Alexander Y Jiu; Shivaani S Gandhi; Nick A Paras; Steven H Olson; Jay Conrad
Journal:  J Org Chem       Date:  2018-07-06       Impact factor: 4.354

3.  Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction.

Authors:  Zhen Wang; Min Zhang; Jin Wang; Haitao Ji
Journal:  J Med Chem       Date:  2019-03-21       Impact factor: 7.446

4.  CuH-Catalyzed Enantioselective Alkylation of Indole Derivatives with Ligand-Controlled Regiodivergence.

Authors:  Yuxuan Ye; Seoung-Tae Kim; Jinhoon Jeong; Mu-Hyun Baik; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2019-02-20       Impact factor: 15.419

5.  Tunable and Cooperative Catalysis for Enantioselective Pictet-Spengler Reaction with Varied Nitrogen-Containing Heterocyclic Carboxaldehydes.

Authors:  Yuk-Cheung Chan; Marcus H Sak; Scott A Frank; Scott J Miller
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-07       Impact factor: 15.336

6.  Recent advances on heterocyclic compounds with antiviral properties.

Authors:  Aramita De; Subhankar Sarkar; Adinath Majee
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-12       Impact factor: 1.277

7.  Unified Synthesis of Polycyclic Alkaloids by Complementary Carbonyl Activation*.

Authors:  Guoli He; Benjamin List; Mathias Christmann
Journal:  Angew Chem Int Ed Engl       Date:  2021-05-01       Impact factor: 15.336

8.  Privileged Structures Revisited.

Authors:  Petra Schneider; Gisbert Schneider
Journal:  Angew Chem Int Ed Engl       Date:  2017-05-30       Impact factor: 15.336

9.  Green synthesis of some 3-(α,α-diarylmethyl)indoles by bio-nanocomposite from embedding L-histidinium trichloroacetate ionic liquid on functionalized magnetite (L-His+CCl3CO2-@PEG@SiO2-nano Fe3O4).

Authors:  Kobra Nikoofar; Narges Saheb Ekhtiari
Journal:  Mol Divers       Date:  2021-07-23       Impact factor: 2.943

10.  Cobalt-catalysed reductive C-H alkylation of indoles using carboxylic acids and molecular hydrogen.

Authors:  Jose R Cabrero-Antonino; Rosa Adam; Kathrin Junge; Matthias Beller
Journal:  Chem Sci       Date:  2017-07-26       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.